15
General Information
DRACP ID DRACP04815
Peptide Name 15
Sequence YSXG
Sequence Length 4
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic
Disulfide/Other Bond Native peptide
N-terminal Modification Free
C-terminal Modification Free
Other Modification X=Cα -dialkylated glycine (Aaa2,2 )
Chiral L
Physicochemical Information
Formula C14H17N3O5
Absent amino acids ACDEFHIKLMNPQRTVW
Common amino acids GSYX
Mass 47099
Pl 6.09
Basic residues 0
Acidic residues 0
Hydrophobic residues 0
Net charge 0
Boman Index -260
Hydrophobicity -62.5
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 1490
Absorbance 280nm 496.67
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 16722632
Title Not available
Doi Not available
Year Not available
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
CancerPPD ID 3917
CancerPPD ID 3918
CancerPPD ID 3919
CancerPPD ID 3920
CancerPPD ID 3921
CancerPPD ID 3922
CancerPPD ID 3923
CancerPPD ID 3924
CancerPPD ID 3925
CancerPPD ID 3926
CancerPPD ID 3927
CancerPPD ID 3928
CancerPPD ID 3929
CancerPPD ID 3930
CancerPPD ID 3931
CancerPPD ID 3932
CancerPPD ID 3933
CancerPPD ID 3934
CancerPPD ID 3935
CancerPPD ID 3936
CancerPPD ID 3937
CancerPPD ID 3938
CancerPPD ID 3939
CancerPPD ID 3940
CancerPPD ID 3941